-
1
-
-
0031938607
-
Current status of solvent/detergent-treated frozen plasma
-
Klein HG, Dodd RY, Dzik WH, et al. Current status of solvent/detergent-treated frozen plasma. Transfusion 1998; 38(1):102-107
-
(1998)
Transfusion
, vol.38
, Issue.1
, pp. 102-107
-
-
Klein, H.G.1
Dodd, R.Y.2
Dzik, W.H.3
-
2
-
-
0026580896
-
Outbreak of hepatitis A among Italian patients with haemophilia
-
Mannucci PM: Outbreak of hepatitis A among Italian patients with haemophilia. Lancet 1992; 339(8796):819
-
(1992)
Lancet
, vol.339
, Issue.8796
, pp. 819
-
-
Mannucci, P.M.1
-
3
-
-
0026543642
-
Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma
-
Horowitz B, Bonomo R, Prince AM, et al. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992; 79(3):826-831
-
(1992)
Blood
, vol.79
, Issue.3
, pp. 826-831
-
-
Horowitz, B.1
Bonomo, R.2
Prince, A.M.3
-
4
-
-
0038692734
-
Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?
-
Williamson LM, Cardigan R, Prowse CV: Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion 2003; 43(9):1322-1329
-
(2003)
Transfusion
, vol.43
, Issue.9
, pp. 1322-1329
-
-
Williamson, L.M.1
Cardigan, R.2
Prowse, C.V.3
-
5
-
-
33746572800
-
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
-
Singh Y, Sawyer LS, Pinkoski LS, et al. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006; 46(7):1168-1177
-
(2006)
Transfusion
, vol.46
, Issue.7
, pp. 1168-1177
-
-
Singh, Y.1
Sawyer, L.S.2
Pinkoski, L.S.3
-
6
-
-
0012620930
-
Riboflavin and UV light inactivate enveloped and non-enveloped viruses in platelet concentrates under conditions which maintain cell quality
-
Goodrich L, Ghielli M, Hansen E, et al. Riboflavin and UV light inactivate enveloped and non-enveloped viruses in platelet concentrates under conditions which maintain cell quality. Vox Sang 2002; 83(Suppl 1):111
-
(2002)
Vox Sang
, vol.83
, Issue.SUPPL. 1
, pp. 111
-
-
Goodrich, L.1
Ghielli, M.2
Hansen, E.3
-
7
-
-
77950239200
-
Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma
-
Smith J, Rock G: Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma. Transfusion 2010; 50(4):926-931
-
(2010)
Transfusion
, vol.50
, Issue.4
, pp. 926-931
-
-
Smith, J.1
Rock, G.2
-
8
-
-
0034490673
-
The effect of virus inactivation on coagulation factors in therapeutic plasma
-
Zeiler T, Wittmann G, Zimmermann R, et al. The effect of virus inactivation on coagulation factors in therapeutic plasma. Br J Haematol 2000; 111(3):986-987
-
(2000)
Br J Haematol
, vol.111
, Issue.3
, pp. 986-987
-
-
Zeiler, T.1
Wittmann, G.2
Zimmermann, R.3
-
9
-
-
0027717248
-
Inactivation of viruses in fresh-frozen plasma
-
Wieding JU, Hellstern P, Kohler M: Inactivation of viruses in fresh-frozen plasma. Ann Hematol 1993; 67(6):259-266
-
(1993)
Ann Hematol
, vol.67
, Issue.6
, pp. 259-266
-
-
Wieding, J.U.1
Hellstern, P.2
Kohler, M.3
-
10
-
-
0037408084
-
Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light
-
Suontaka AM, Blomback M, Chapman J: Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light. Transfusion 2003; 43(5):568-575
-
(2003)
Transfusion
, vol.43
, Issue.5
, pp. 568-575
-
-
Suontaka, A.M.1
Blomback, M.2
Chapman, J.3
-
11
-
-
13544277096
-
Solvent/detergent-treated plasma: composition, efficacy, and safety
-
Hellstern P: Solvent/detergent-treated plasma: composition, efficacy, and safety. Curr Opin Hematol 2004; 11(5):346-350
-
(2004)
Curr Opin Hematol
, vol.11
, Issue.5
, pp. 346-350
-
-
Hellstern, P.1
-
12
-
-
0038057391
-
Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma
-
Doyle S, O'Brien P, Murphy K, et al. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 2003; 14(3):283-287
-
(2003)
Blood Coagul Fibrinolysis
, vol.14
, Issue.3
, pp. 283-287
-
-
Doyle, S.1
O'Brien, P.2
Murphy, K.3
-
13
-
-
8944220236
-
Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group
-
Rock G, Shumak KH, Sutton DM, et al. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group. Br J Haematol 1996; 94(2):383-386
-
(1996)
Br J Haematol
, vol.94
, Issue.2
, pp. 383-386
-
-
Rock, G.1
Shumak, K.H.2
Sutton, D.M.3
-
14
-
-
33644651068
-
The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma-response to McCarthy
-
Rock G: The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma-response to McCarthy. Br J Haematol 2006; 133:108
-
(2006)
Br J Haematol
, vol.133
, pp. 108
-
-
Rock, G.1
-
15
-
-
62349127703
-
Properties of pathogen-inactivated plasma components
-
Prowse C: Properties of pathogen-inactivated plasma components. Transfus Med Rev 2009; 23(2):124-133
-
(2009)
Transfus Med Rev
, vol.23
, Issue.2
, pp. 124-133
-
-
Prowse, C.1
-
16
-
-
0032776380
-
Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma
-
Aznar JA, Molina R, Montoro JM: Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma. Transfusion 1999; 39(7):748-750
-
(1999)
Transfusion
, vol.39
, Issue.7
, pp. 748-750
-
-
Aznar, J.A.1
Molina, R.2
Montoro, J.M.3
-
17
-
-
0034785795
-
Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura
-
De la Rubia J, Arriaga F, Linares D, et al. Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. Br J Haematol 2001; 114(3):721-723
-
(2001)
Br J Haematol
, vol.114
, Issue.3
, pp. 721-723
-
-
De la Rubia, J.1
Arriaga, F.2
Linares, D.3
-
18
-
-
3142515949
-
Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura
-
Alvarez-Larran A, Del RJ, Ramirez C, et al. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sang 2004; 86(4):246-251
-
(2004)
Vox Sang
, vol.86
, Issue.4
, pp. 246-251
-
-
Alvarez-Larran, A.1
Del, R.J.2
Ramirez, C.3
-
19
-
-
23844453081
-
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies
-
de Alarcon P, Benjamin R, Dugdale M, et al. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion 2005; 45(8):1362-1372
-
(2005)
Transfusion
, vol.45
, Issue.8
, pp. 1362-1372
-
-
de Alarcon, P.1
Benjamin, R.2
Dugdale, M.3
-
20
-
-
27844470244
-
Coagulation factor levels in cryosupernatant treated with amotosalen HCl (S-59) and UVA light-a suitable plasma replacement in thrombotic thrombocytopenic purpura
-
2003: 817a
-
Yarranton H, Lawrie AS, Mackie IJ, et al. Coagulation factor levels in cryosupernatant treated with amotosalen HCl (S-59) and UVA light-a suitable plasma replacement in thrombotic thrombocytopenic purpura. Blood 2003; 102 (11; part1), 2003: 817a
-
(2003)
Blood
, vol.102
, Issue.11 PART 1
-
-
Yarranton, H.1
Lawrie, A.S.2
Mackie, I.J.3
-
21
-
-
0037929757
-
Pathogen inactivated transfusion plasma: existing and emerging methods
-
Horowitz B: Pathogen inactivated transfusion plasma: existing and emerging methods. Vox Sang 2002; 83(S1):429-436
-
(2002)
Vox Sang
, vol.83
, Issue.S1
, pp. 429-436
-
-
Horowitz, B.1
-
22
-
-
0033668693
-
Solvent-detergent treated fresh frozen plasma: a superior alternative to standard fresh frozen plasma?
-
Sharma D, Sreeram G, Erb T, et al. Solvent-detergent treated fresh frozen plasma: a superior alternative to standard fresh frozen plasma? J Cardiothorac Vasc Anesth 2000; 14:712-717
-
(2000)
J Cardiothorac Vasc Anesth
, vol.14
, pp. 712-717
-
-
Sharma, D.1
Sreeram, G.2
Erb, T.3
-
23
-
-
17044428503
-
Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light
-
Lin L, Hanson CV, Alter HJ, et al. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005; 45(4):580-590
-
(2005)
Transfusion
, vol.45
, Issue.4
, pp. 580-590
-
-
Lin, L.1
Hanson, C.V.2
Alter, H.J.3
-
24
-
-
70350462130
-
Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins
-
Hornsey VS, Drummond O, Morrison A, et al. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins. Transfusion 2009; 49(10):2167-2172
-
(2009)
Transfusion
, vol.49
, Issue.10
, pp. 2167-2172
-
-
Hornsey, V.S.1
Drummond, O.2
Morrison, A.3
-
25
-
-
74549226197
-
Characterization of plasma protein activity in riboflavinand UV light-treated fresh frozen plasma during 2 years of storage at -30°C
-
Bihm D, Ettinger A, Buytaert-Hoefen K, et al. Characterization of plasma protein activity in riboflavinand UV light-treated fresh frozen plasma during 2 years of storage at -30°C. Vox Sang 2010; 98:108-115
-
(2010)
Vox Sang
, vol.98
, pp. 108-115
-
-
Bihm, D.1
Ettinger, A.2
Buytaert-Hoefen, K.3
-
26
-
-
0031823643
-
In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma
-
Beeck H, Hellstern P: In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma. Vox Sang 1998; 74(Suppl 1):219-223
-
(1998)
Vox Sang
, vol.74
, Issue.SUPPL. 1
, pp. 219-223
-
-
Beeck, H.1
Hellstern, P.2
-
27
-
-
0033857903
-
Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is it decreased protein S activity related to their development of deep venous thromboses?
-
Flamholtz R, Jean H, Barron J, et al. Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is it decreased protein S activity related to their development of deep venous thromboses? J Clin Apher 2000; 15:169-172
-
(2000)
J Clin Apher
, vol.15
, pp. 169-172
-
-
Flamholtz, R.1
Jean, H.2
Barron, J.3
-
28
-
-
33746460956
-
Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?
-
Salge-Bartels U, Breitner-Ruddock S, Hunfeld A, et al. Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe? Transfus Med 2006; 16(4):266-275
-
(2006)
Transfus Med
, vol.16
, Issue.4
, pp. 266-275
-
-
Salge-Bartels, U.1
Breitner-Ruddock, S.2
Hunfeld, A.3
-
29
-
-
70349527966
-
Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time
-
Heger A, Svae TE, Neisser-Svae A, et al. Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time. Vox Sang 2009; 97(3):219-225
-
(2009)
Vox Sang
, vol.97
, Issue.3
, pp. 219-225
-
-
Heger, A.1
Svae, T.E.2
Neisser-Svae, A.3
-
30
-
-
0037600705
-
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura
-
Yarranton H, Cohen H, Pavord SR, et al. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 2003; 121(5):778-785
-
(2003)
Br J Haematol
, vol.121
, Issue.5
, pp. 778-785
-
-
Yarranton, H.1
Cohen, H.2
Pavord, S.R.3
-
31
-
-
1542406172
-
Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter
-
Crettaz D, Sensebe L, Vu DH, et al. Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter. Proteomics 2004; 4(3):881-891
-
(2004)
Proteomics
, vol.4
, Issue.3
, pp. 881-891
-
-
Crettaz, D.1
Sensebe, L.2
Vu, D.H.3
-
32
-
-
0028114095
-
The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma
-
Zeiler T, Riess H, Wittmann G, et al. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion 1994; 34(8):685-689
-
(1994)
Transfusion
, vol.34
, Issue.8
, pp. 685-689
-
-
Zeiler, T.1
Riess, H.2
Wittmann, G.3
-
33
-
-
22144477855
-
The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices
-
Depasse F, Sensebe L, Seghatchian J, et al. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices. Transfus Apher Sci 2005; 33(1):63-69
-
(2005)
Transfus Apher Sci
, vol.33
, Issue.1
, pp. 63-69
-
-
Depasse, F.1
Sensebe, L.2
Seghatchian, J.3
-
34
-
-
0033673215
-
Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants
-
Aznar JA, Bonanad S, Montoro JM, et al. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants. Vox Sang 2000; 79(3):156-160
-
(2000)
Vox Sang
, vol.79
, Issue.3
, pp. 156-160
-
-
Aznar, J.A.1
Bonanad, S.2
Montoro, J.M.3
-
35
-
-
47749155632
-
Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma
-
Liumbruno GM, Sodini ML, Grazzini G: Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Blood Transfus 2008; 6(1):25-36
-
(2008)
Blood Transfus
, vol.6
, Issue.1
, pp. 25-36
-
-
Liumbruno, G.M.1
Sodini, M.L.2
Grazzini, G.3
-
36
-
-
37549049779
-
Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen
-
Osselaer JC, Debry C, Goffaux M, et al. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008; 48(1):108-117
-
(2008)
Transfusion
, vol.48
, Issue.1
, pp. 108-117
-
-
Osselaer, J.C.1
Debry, C.2
Goffaux, M.3
-
37
-
-
1842715059
-
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura
-
Yarranton H, Lawrie AS, Purdy G, et al. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med 2004; 14(1):39-44
-
(2004)
Transfus Med
, vol.14
, Issue.1
, pp. 39-44
-
-
Yarranton, H.1
Lawrie, A.S.2
Purdy, G.3
-
38
-
-
41149163375
-
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers
-
Schlenke P, Hervig T, Isola H, et al. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion 2008; 48(4):697-705
-
(2008)
Transfusion
, vol.48
, Issue.4
, pp. 697-705
-
-
Schlenke, P.1
Hervig, T.2
Isola, H.3
-
39
-
-
71549147205
-
The influence of riboflavin photochemistry on plasma coagulation factors
-
Larrea L, Calabuig M, Roldan V, et al. The influence of riboflavin photochemistry on plasma coagulation factors. Transfus Apher Sci 2009; 41(3):199-204
-
(2009)
Transfus Apher Sci
, vol.41
, Issue.3
, pp. 199-204
-
-
Larrea, L.1
Calabuig, M.2
Roldan, V.3
-
40
-
-
33847616443
-
Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development
-
Heger A, Kannicht C, Romisch J, et al. Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development. Vox Sang 2007; 92(3):206-212
-
(2007)
Vox Sang
, vol.92
, Issue.3
, pp. 206-212
-
-
Heger, A.1
Kannicht, C.2
Romisch, J.3
-
41
-
-
23844532601
-
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction
-
AuBuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45(8):1335-1341
-
(2005)
Transfusion
, vol.45
, Issue.8
, pp. 1335-1341
-
-
AuBuchon, J.P.1
Herschel, L.2
Roger, J.3
-
42
-
-
33644812836
-
Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial
-
Snyder E, McCullough J, Slichter SJ, et al. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005; 45(12):1864-1875
-
(2005)
Transfusion
, vol.45
, Issue.12
, pp. 1864-1875
-
-
Snyder, E.1
McCullough, J.2
Slichter, S.J.3
-
43
-
-
34547668747
-
A comparison of complication rates based on published haemovigilance data
-
Flesland O: A comparison of complication rates based on published haemovigilance data. Intensive Care Med 2010; 33(1):S17-S21
-
(2010)
Intensive Care Med
, vol.33
, Issue.1
-
-
Flesland, O.1
-
44
-
-
51249088766
-
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study
-
del Rio-Garma J, Alvarez-Larran A, Martinez C, et al. Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol 2008; 143(1):39-45
-
(2008)
Br J Haematol
, vol.143
, Issue.1
, pp. 39-45
-
-
del Rio-Garma, J.1
Alvarez-Larran, A.2
Martinez, C.3
-
45
-
-
78651316055
-
-
Committee for medicinal product for human use (CHMP) guideline on plasma-derived medicinal products. London.
-
Committee for medicinal product for human use (CHMP) guideline on plasma-derived medicinal products. London 2009, 26p
-
(2009)
, pp. 26
-
-
-
46
-
-
0028936392
-
Photodynamic virus inactivation of blood components
-
Mohr H, Lambrecht B, Selz A: Photodynamic virus inactivation of blood components. Immunol Invest 1995; 2:73-85
-
(1995)
Immunol Invest
, vol.2
, pp. 73-85
-
-
Mohr, H.1
Lambrecht, B.2
Selz, A.3
-
47
-
-
44949224338
-
Updates on pathogen inactivation of plasma using Theraflex methylene blue system
-
Seghatchian J, Walker WH, Reichenberg S: Updates on pathogen inactivation of plasma using Theraflex methylene blue system. Transfus Apher Sci 2008; 38(3):271-280
-
(2008)
Transfus Apher Sci
, vol.38
, Issue.3
, pp. 271-280
-
-
Seghatchian, J.1
Walker, W.H.2
Reichenberg, S.3
-
48
-
-
2942597938
-
West Nile virus in plasma is highly sensitive to methylene blue-light treatment
-
Mohr H, Knuver-Hopf J, Gravemann U, et al. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion 2004; 44(6):886-890
-
(2004)
Transfusion
, vol.44
, Issue.6
, pp. 886-890
-
-
Mohr, H.1
Knuver-Hopf, J.2
Gravemann, U.3
-
49
-
-
2942558817
-
Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light
-
Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44(6):877-885
-
(2004)
Transfusion
, vol.44
, Issue.6
, pp. 877-885
-
-
Ruane, P.H.1
Edrich, R.2
Gampp, D.3
-
50
-
-
0031853914
-
Solvent/detergent treatment of human plasma - a very robust method for virus inactivation. Validated virus safety of OCTAPLAS
-
Biesert L, Suhartono H: Solvent/detergent treatment of human plasma - a very robust method for virus inactivation. Validated virus safety of OCTAPLAS. Vox Sang 1998; 74(Suppl 1):207-212
-
(1998)
Vox Sang
, vol.74
, Issue.SUPPL. 1
, pp. 207-212
-
-
Biesert, L.1
Suhartono, H.2
-
51
-
-
0042430604
-
West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data
-
Kreil TR, Berting A, Kistner O, et al. West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data. Transfusion 2003; 43(8):1023-1028
-
(2003)
Transfusion
, vol.43
, Issue.8
, pp. 1023-1028
-
-
Kreil, T.R.1
Berting, A.2
Kistner, O.3
-
52
-
-
0033867721
-
Viral inactivation of fresh frozen plasma
-
Pamphilon D: Viral inactivation of fresh frozen plasma. Br J Haematol 2000; 109(4):680-693
-
(2000)
Br J Haematol
, vol.109
, Issue.4
, pp. 680-693
-
-
Pamphilon, D.1
-
53
-
-
0034003693
-
Resistance of vaccinia virus to inactivation by solvent detergent treatment of blood products
-
Roberts P: Resistance of vaccinia virus to inactivation by solvent detergent treatment of blood products. Biologicals 2000; 28:29-32
-
(2000)
Biologicals
, vol.28
, pp. 29-32
-
-
Roberts, P.1
-
54
-
-
33748475913
-
Update on pathogen reduction technology for therapeutic plasma: an overview
-
Solheim BG, Seghatchian J: Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 2006; 35(1):83-90
-
(2006)
Transfus Apher Sci
, vol.35
, Issue.1
, pp. 83-90
-
-
Solheim, B.G.1
Seghatchian, J.2
-
55
-
-
34249102861
-
Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination
-
Sawyer L, Hanson D, Castro G, et al. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination. Transfusion 2007; 47(6):1062-1070
-
(2007)
Transfusion
, vol.47
, Issue.6
, pp. 1062-1070
-
-
Sawyer, L.1
Hanson, D.2
Castro, G.3
-
56
-
-
33748327070
-
Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice
-
Fast LD, DiLeone G, Cardarelli G, et al. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion 2006; 46(9):1553-1560
-
(2006)
Transfusion
, vol.46
, Issue.9
, pp. 1553-1560
-
-
Fast, L.D.1
DiLeone, G.2
Cardarelli, G.3
-
57
-
-
0033135739
-
Prevention of transfusion-associated graft-versus-host disease by photochemical treatment
-
Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999; 93(9):3140-3147
-
(1999)
Blood
, vol.93
, Issue.9
, pp. 3140-3147
-
-
Grass, J.A.1
Wafa, T.2
Reames, A.3
-
58
-
-
66549125829
-
A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns
-
Goodrich RP, Gilmour D, Hovenga N, et al. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion 2009; 49(6):1205-1216
-
(2009)
Transfusion
, vol.49
, Issue.6
, pp. 1205-1216
-
-
Goodrich, R.P.1
Gilmour, D.2
Hovenga, N.3
-
59
-
-
34248145455
-
Pathogen inactivation: the definitive safeguard for the blood supply
-
Bryant BJ, Klein HG: Pathogen inactivation: the definitive safeguard for the blood supply. Arch Pathol Lab Med 2007; 131(5):719-733
-
(2007)
Arch Pathol Lab Med
, vol.131
, Issue.5
, pp. 719-733
-
-
Bryant, B.J.1
Klein, H.G.2
-
60
-
-
68149125565
-
Emerging infectious disease agents and their potential threat to transfusion safety
-
Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49(Suppl 2):1S-29S
-
(2009)
Transfusion
, vol.49
, Issue.SUPPL. 2
-
-
Stramer, S.L.1
Hollinger, F.B.2
Katz, L.M.3
-
61
-
-
78651273373
-
Photochemical Inactivation of Chikungunya Virus Using the Mirasol® Pathogen Reduction Technology (PRT) System
-
Keil S, Vanlandingham D, Tsetsarkin K, et al. Photochemical Inactivation of Chikungunya Virus Using the Mirasol® Pathogen Reduction Technology (PRT) System. Transfusion 2008; 48(Suppl 2):101A
-
(2008)
Transfusion
, vol.48
, Issue.SUPPL. 2
-
-
Keil, S.1
Vanlandingham, D.2
Tsetsarkin, K.3
-
62
-
-
77951678635
-
Evaluation of Mirasol Pathogen Reduction Technology System for reduction of Babesia microti in apheresis platelets and plasma
-
Tonnetti L, Proctor M, Reddy HL, et al. Evaluation of Mirasol Pathogen Reduction Technology System for reduction of Babesia microti in apheresis platelets and plasma. Transfusion 2010; 50(5):1091-1027
-
(2010)
Transfusion
, vol.50
, Issue.5
, pp. 1091-1027
-
-
Tonnetti, L.1
Proctor, M.2
Reddy, H.L.3
-
63
-
-
78651289289
-
Inactivation of Plasmodium falciparum in plasma and platelet concentrates with riboflavin and UV light
-
in press
-
Sullivan J, Bounngaseng A, Reddy H, et al. Inactivation of Plasmodium falciparum in plasma and platelet concentrates with riboflavin and UV light. Transfusion 2010; in press
-
(2010)
Transfusion
-
-
Sullivan, J.1
Bounngaseng, A.2
Reddy, H.3
-
64
-
-
66549089024
-
Inactivation of Chikungunya virus in plasma and platelets using the INTERCEPT blood system
-
Sawyer LS, Sampson J, Dubensky T, et al. Inactivation of Chikungunya virus in plasma and platelets using the INTERCEPT blood system. Vox Sang 2007; 91(Suppl 1):170
-
(2007)
Vox Sang
, vol.91
, Issue.SUPPL. 1
, pp. 170
-
-
Sawyer, L.S.1
Sampson, J.2
Dubensky, T.3
-
65
-
-
36549038538
-
Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light
-
Cardo LJ, Salata J, Mendez J, et al. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007; 37(2):131-137
-
(2007)
Transfus Apher Sci
, vol.37
, Issue.2
, pp. 131-137
-
-
Cardo, L.J.1
Salata, J.2
Mendez, J.3
-
66
-
-
33750868542
-
The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma
-
Girones N, Bueno JL, Carrion J, et al. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma. Vox Sang 2006; 91(4):285-291
-
(2006)
Vox Sang
, vol.91
, Issue.4
, pp. 285-291
-
-
Girones, N.1
Bueno, J.L.2
Carrion, J.3
-
67
-
-
33846417644
-
Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model
-
Rentas F, Harman R, Gomez C, et al. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007; 47(2):240-247
-
(2007)
Transfusion
, vol.47
, Issue.2
, pp. 240-247
-
-
Rentas, F.1
Harman, R.2
Gomez, C.3
-
68
-
-
33644893088
-
Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light
-
Cardo LJ, Rentas FJ, Ketchum L, et al. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006; 90(2):85-91
-
(2006)
Vox Sang
, vol.90
, Issue.2
, pp. 85-91
-
-
Cardo, L.J.1
Rentas, F.J.2
Ketchum, L.3
-
69
-
-
70349559216
-
Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG
-
Neisser-Svae A, Bailey A, Gregori L, et al. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG. Vox Sang 2009; 97(3):226-233
-
(2009)
Vox Sang
, vol.97
, Issue.3
, pp. 226-233
-
-
Neisser-Svae, A.1
Bailey, A.2
Gregori, L.3
-
70
-
-
66549083222
-
Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Reunion
-
Rasongles P, Angelini-Tibert MF, Simon P, et al. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Reunion. Transfusion 2009; 49(6):1083-1091
-
(2009)
Transfusion
, vol.49
, Issue.6
, pp. 1083-1091
-
-
Rasongles, P.1
Angelini-Tibert, M.F.2
Simon, P.3
-
71
-
-
84855637240
-
® Pathogen Reduction Technology
-
in press
-
® Pathogen Reduction Technology. Transfusion 2010; in press
-
(2010)
Transfusion
-
-
Goodrich, R.P.1
-
72
-
-
47349103797
-
Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma?
-
Hellstern P: Fresh-frozen plasma, pathogen-reduced single-donor plasma or bio-pharmaceutical plasma? Transfus Apher Sci 2008; 39(1):69-74
-
(2008)
Transfus Apher Sci
, vol.39
, Issue.1
, pp. 69-74
-
-
Hellstern, P.1
-
73
-
-
40749084854
-
Pathogen reduction: a precautionary principle paradigm
-
Alter HJ: Pathogen reduction: a precautionary principle paradigm. Transfus Med Rev 2008; 22(2):97-102
-
(2008)
Transfus Med Rev
, vol.22
, Issue.2
, pp. 97-102
-
-
Alter, H.J.1
-
74
-
-
27744519678
-
Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment
-
Lin L, Conlan MG, Tessman J, et al. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion 2005; 45(10):1610-1620
-
(2005)
Transfusion
, vol.45
, Issue.10
, pp. 1610-1620
-
-
Lin, L.1
Conlan, M.G.2
Tessman, J.3
-
75
-
-
0013419903
-
Validation of virus inactivation in human plasma using blood bag system MB959D and Maco-tronic illumination device
-
Lambrecht B, Mohr H, Goudaliez F, et al. Validation of virus inactivation in human plasma using blood bag system MB959D and Maco-tronic illumination device. Vox Sang 2000; 79(Suppl 1):P544
-
(2000)
Vox Sang
, vol.79
, Issue.SUPPL. 1
-
-
Lambrecht, B.1
Mohr, H.2
Goudaliez, F.3
-
76
-
-
0025893790
-
Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light
-
Lambrecht B, Mohr H, Knuver-Hopf J, et al. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 1991; 60(4):207-213
-
(1991)
Vox Sang
, vol.60
, Issue.4
, pp. 207-213
-
-
Lambrecht, B.1
Mohr, H.2
Knuver-Hopf, J.3
-
77
-
-
33748445931
-
The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends
-
Goodrich RP, Edrich RA, Li J, et al. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006; 35(1):5-17
-
(2006)
Transfus Apher Sci
, vol.35
, Issue.1
, pp. 5-17
-
-
Goodrich, R.P.1
Edrich, R.A.2
Li, J.3
|